UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

SCHEDULE 13G
Under the Securities Exchange Act of 1934

Amendment No.:

Name of Issuer: CURAGEN CORPORATION

Title of Class of Securities:  COMMON STOCK $.01 PAR VALUE

CUSIP Number: 23126R101


Check the following line if a fee is being paid with this statement.  (A fee is
not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however,
see the Notes).

1.       Name of Reporting Person and S.S. or I.R.S. Identification
         No of Above Person:     Pequot Capital Management, Inc.
                                 Tax ID:  06-1524885

2.       Check the Appropriate Box if a Member of a Group
           a.
           b.

3.       SEC Use Only

4.       Citizenship or Place of Organization:
          Connecticut

Number of Shares Beneficially Owned by Each Reporting Person With:

5.       Sole Voting Power:       1,874,800

6.       Shared Voting Power:   0

7.       Sole Dispositive Power: 1,874,800

8.       Shared Dispositive Power: 0

9.       Aggregate Amount Beneficially
          Owned by Each Reporting Person:   1,874,800

10.    Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares:

11.    Percent of Class Represented by Amount in Row (9):     11.18%

12.    Type of Reporting Person:     IA, CO


Item 1(a) Name of Issuer:  CURAGEN CORPORATION

        1(b) Address of Issuer's Principal Executive Offices:
              555 Long Wharf Drive, 11th Floor, New Haven, CT, 06511

Item 2(a) - (c). Name, Principal Business Address, and Citizenship of Persons
                 Filing:
              Pequot Capital Management, Inc., 500 Nyala Farm Road,
              Westport, CT 06880, which is a Connecticut corporation.

      (d)          Title of Class of Securities: COMMON STOCK $.01 PAR VALUE

      (e)          CUSIP Number: 23126R101

Item 3.    This statement is filed pursuant to Rule 13d-1(b)(1)(ii)(E)
           Pequot Capital Management, Inc. is an investment adviser registered
           under Section 203 of the Investment Advisers Act of 1940.

Item 4.    Ownership.
  Ownership as of September 30, 1999 is incorporated by reference to items
  (5) - (9) and (11) of the cover page of the reporting person.

Item 5.    Ownership of Five Percent or Less of a Class.
           If this statement is being filed to report the fact that as of the
           date hereof the reporting person has ceased to be the beneficial
           owner of more than five percent of the class of securities, check
           the following.

Item 6.    Ownership of More than Five Percent on Behalf of Another Person.
           The reporting person is an investment adviser registered under
           Section 203 of the Investment Advisers Act of 1940, and as such, has
           the beneficial ownership of the shares which are the subject of this
           filing through the investment discretion the reporting person
           exercises over its clients' accounts.

Item 7.    Identification and Classification of the Subsidiary Which Acquired
           the Security Being Reported by the Parent Holding Company.
           Not applicable.

Item 8.    Identification and Classification of Members of the Group.
           Not applicable.

Item 9.    Notice of Dissolution of the Group.
           Not applicable.

Item 10.

By signing below, I certify that, to the best of my knowledge and belief, the
securities referred to above were acquired in the ordinary course of business
and were not acquired for the purpose and do not have the effect of changing or
influencing the control of the issuer of such securities and were not acquired
in connection with or as a participant in any transaction having such purpose
or effect.

After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.


Date: October 6, 1999

By: /s/  David J. Malat
  Title: Chief Financial Officer